Vident Investment Advisory’s Medifast MED Stock Holding History

Vident Investment Advisory’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,985	Closed	-$2.39M	–	619
2023 Q2	$2.39M	Buy	25,985 +1,620	+7%	+$144K	0.08%	269
2023 Q1	$2.53M	Buy	24,365 +5,215	+27%	+$578K	0.08%	270
2022 Q4	$2.21M	Buy	+19,150	New	+$2.23M	0.08%	274
2018 Q4	–	Sell	-909	Closed	-$201K	–	857
2018 Q3	$201K	Buy	+909	New	+$184K	0.01%	904

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vident Investment Advisory's MED Position: Q3 2023 in Review

Vident Investment Advisory sold out of Medifast (MED) in Q3 2023, closing a stake of 25,985 shares — an estimated $2.39M sold.

Vident Investment Advisory first reported a position in MED in Q3 2018 and held it in 4 quarters. The position peaked at $2.53M in Q1 2023. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

Vident Investment Advisory reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
Vident Investment Advisory sold 25,985 Medifast shares in Q3 2023, an estimated $2.39M.
Vident Investment Advisory first reported a position in Medifast in Q3 2018 and held it in 4 quarters.
Vident Investment Advisory's Medifast position peaked at $2.53M in Q1 2023.
223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.